This is Snapshot #3 for FHIR R5, released to support Connectathon 32. For a full list of available versions, see the Directory of published versions.
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw Turtle (+ also see Turtle/RDF Format Specification)
Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- [a fhir:EvidenceVariable; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort"]; # fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>\n Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis\n </p>\n </div>" ]; # fhir:EvidenceVariable.name [ fhir:value "Stroke Thrombolysis Trialists’ 2014-2016 IPD-MA Cohort"]; # fhir:EvidenceVariable.title [ fhir:value "Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis"]; # fhir:EvidenceVariable.status [ fhir:value "draft"]; # fhir:EvidenceVariable.relatedArtifact [ fhir:index 0; fhir:RelatedArtifact.type [ fhir:value "citation" ]; fhir:RelatedArtifact.label [ fhir:value "Emberson 2014" ]; fhir:RelatedArtifact.display [ fhir:value "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials." ]; fhir:RelatedArtifact.citation [ fhir:value "Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063" ]; fhir:RelatedArtifact.document [ fhir:Attachment.url [ fhir:value "https://doi.org/10.1016/S0140-6736(14)60584-5" ] ] ], [ fhir:index 1; fhir:RelatedArtifact.type [ fhir:value "citation" ]; fhir:RelatedArtifact.label [ fhir:value "Lees 2016" ]; fhir:RelatedArtifact.display [ fhir:value "Figure 2 Lees 2016" ]; fhir:RelatedArtifact.citation [ fhir:value "Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856" ]; fhir:RelatedArtifact.document [ fhir:Attachment.url [ fhir:value "https://doi.org/10.1161/STROKEAHA.116.013644" ] ] ]; # fhir:EvidenceVariable.actual [ fhir:value "true"^^xsd:boolean]; # fhir:EvidenceVariable.characteristic [ fhir:index 0; fhir:EvidenceVariable.characteristic.description [ fhir:value "Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis" ]; fhir:EvidenceVariable.characteristic.definitionByCombination [ fhir:EvidenceVariable.characteristic.definitionByCombination.code [ fhir:value "any-of" ]; fhir:EvidenceVariable.characteristic.definitionByCombination.characteristic [ fhir:index 0; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/ECASSIII-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "ECASS III Trial Cohort" ] ] ], [ fhir:index 1; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/IST3-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "IST3 Trial Cohort" ] ] ], [ fhir:index 2; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/ECASS-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "ECASS Trial Cohort" ] ] ], [ fhir:index 3; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/ECASSII-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "ECASSII Trial Cohort" ] ] ], [ fhir:index 4; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/EPITHET-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "EPITHET Trial Cohort" ] ] ], [ fhir:index 5; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/ATLANTIS-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "ATLANTIS Trial Cohort" ] ] ], [ fhir:index 6; fhir:EvidenceVariable.characteristic.definitionReference [ fhir:Reference.reference [ fhir:value "Group/NINDS-Trial-Cohort" ]; fhir:Reference.type [ fhir:value "Group" ]; fhir:Reference.display [ fhir:value "NINDS Trial Cohort" ] ] ] ] ]] . # # - ontology header ------------------------------------------------------------ [a owl:Ontology; owl:imports fhir:fhir.ttl] . # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-snapshot3 generated on Wed, Dec 14, 2022 07:16+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change